Delivery Order SPE2DB22D1106-SPE2DB25FEZU9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,287.32 to AmerisourceBergen Drug Corp for 60 tablets of Vimpat 100 mg on August 26, 2025, with completion scheduled for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The $1,328.28 contract is for the supply of Vimpat 10 mg/ml solution in 200 ml bottles. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as a single awardee, with a potential value up to...
- This is a $1,293.61 Firm Fixed Price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Vimpat 10 mg/ml solution, a neurological medication. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vimpat 10 mg/ml solution (200 ml). The contract has a ceiling value of $1,962.35 and is a Firm Fixed Price (FFP) arrangement with a completion date of February 11, 2025. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of Vimpat 10 mg/ml solution in 200 ml bottles, with a ceiling value of $2,026.56 and an ultimate completion date of January 20, 2022. The contract is a firm fixed-price delivery order and was awarded on January 19, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of Vimpat 10 mg/ml solution in 200 ml bottles, with a ceiling value of $1,174.32 and a performance period ending on March 11, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 10 mg/ml Vimpat solution in 200 ml containers. The $1,223.04 firm fixed price contract has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,279.00 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of VIMPAT 10 mg/mL solution in 200mL quantities. This is a firm fixed price, non-set-aside contract with a completion date of June 6, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- This federal contract award is for the delivery of Vimpat 10 mg/ml solution in 200 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $1,688.80, was awarded to the prime contractor Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,670.96 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution (200 mL), a pharmaceutical product used in neurological treatment. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The award carries no set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZU9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,495.07 to AmerisourceBergen Drug Corp for the supply of Vimpat 10 mg/ml solution in a 200 ml quantity. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's larger pharmaceutical supply relationship with the federal government. This award is executed as a child contract under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications and medical supplies to support military healthcare programs worldwide. Vimpat, an antiepileptic medication, represents one of many pharmaceutical products the contractor delivers through this vehicle to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/25/25 |